Health Canada
www.hc-sc.gc.ca
Common menu bar links
Institutional links
Drugs and Health Products
Consultation
Effective consultation is essential to allow Health Canada to fulfill its legislative mandate, deliver programs, and launch new initiatives. Canadians are provided an opportunity to be involved in decision-making processes regarding Health Canada's priorities, policies and programs.
- Consultation on the Plain Language Labelling Initiative [2013-06-24]
- Information for Industry on the proposed regulatory amendment for a Fact Table [2013-06-24]
- Information for Canadians about the Plain Language Labelling Initiative [2013-06-24]
- Information for Industry on the proposed regulatory amendments to submit mock-ups of labels [2013-06-24]
- Consultation - Draft Guidance Document: Disinfectant Drugs [2013-04-02]
- International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) S1: Proposed Change to Rodent Carcinogenicity Testing of Pharmaceuticals - Regulatory Notice for Public Input [2013-02-05]
- Consultation on Health Canada's Public Clinical Trials Database [2012-12-13]
- Draft Guidance Document: Biopharmaceutics Classification System Based Biowaver [2012-08-21]
- Draft Guidance Document: Acetylsalicylic Acid Labelling Standard [2012-07-27]
